(Q51169302)

31 March 2018

title

L-arginine for the treatment of centrally obese subjects: a pilot study. (English)

1 reference

31 March 2018

0 references

Ryan T Hurt

1

1 reference

31 March 2018

Jon O Ebbert

2

1 reference

31 March 2018

Darrell R Schroeder

3

1 reference

31 March 2018

Ivana T Croghan

4

1 reference

31 March 2018

Brent A Bauer

5

1 reference

31 March 2018

Stephen A McClave

6

1 reference

31 March 2018

John M Miles

7

1 reference

31 March 2018

Craig J McClain

8

1 reference

31 March 2018

language of work or name

English

0 references

publication date

10 January 2014

1 reference

31 March 2018

Journal of Dietary Supplements

published in

1 reference

31 March 2018

volume

11

1 reference

31 March 2018

issue

1

1 reference

31 March 2018

page(s)

40-52

1 reference

31 March 2018

Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients

cites work

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Obesity, inflammation, and the potential application of pharmaconutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

A reappraisal of diagnosing GH deficiency in adults: role of gender, age, waist circumference, and body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Long-term weight loss after diet and exercise: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Abdominal obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Central obesity and multivariable cardiovascular risk as assessed by the Framingham prediction scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Obesity and inflammation: should the principles of immunonutrition be applied to this disease process?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Pharmaconutrition for the obese, critically ill patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Obesity epidemic: overview, pathophysiology, and the intensive care unit conundrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Pharmacotherapies for obesity: past, current, and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

High fat feeding and dietary L-arginine supplementation differentially regulate gene expression in rat white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Dietary L-arginine supplementation reduces white fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Development of a brief measure to assess quality of life in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

GH/IGF-I regulation in obesity--mechanisms and practical consequences in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Nutrition therapy of the severely obese, critically ill patient: summation of conclusions and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Beneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Dietary L-arginine supplementation increases muscle gain and reduces body fat mass in growing-finishing pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Adipokine protein expression pattern in growth hormone deficiency predisposes to the increased fat cell size and the whole body metabolic derangements.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Arginine metabolism and nutrition in growth, health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F19390211.2013.859216

10.3109/19390211.2013.859216

21 January 2018

Identifiers

DOI

1 reference

31 March 2018

PubMed ID

24409974

1 reference

31 March 2018